Invivyd Inc
IVVD
Get informed when a big investor buys or sells
+ FollowMarket Cap$212.38M
Close$
$4.30
527.8% upside
Current Fair Value
527.8% upsideUndervalued by 527.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $212.38 Million |
|---|---|
| Enterprise Value | $60.69 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.3 |
| Beta | 0.71 |
| Outstanding Shares | 320,435,078 |
Return
| Return on Equity | -59.27% |
|---|---|
| Return on Assets | -49.04% |
| Return on Invested Capital | -60.10% |
Valuation & Multiples
| P/E Ratio | -1.83 |
|---|---|
| PEG | -0.9 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.04 |
| Enterprise Value to EBIT | -0.54 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$14.40 M
Average shareholder expectationNext Earnings Call
Expected Date
August 19, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$20.06 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3663▼ 22.50% |
|---|---|
| Total Calls | 561,000▼ 19.97% |
| Total Puts | 205,500▼ 50.42% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 131.50%▼ 7.96% |
|---|---|
| Total Invested | $294.24M▼ 50.44% |
| Investors Holding | 146▲ 25.00% |
ESG Score
No data
About Invivyd Inc
2,021 employeesAdagio (Nasdaq: ADGI) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antib...